← Leaderboards
Jason Gardner
Progenics Pharmaceuticals, Inc.
$961,024
Attributed
$961,024
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$961,024 · 2
By mechanism
R43$961,024 · 2
Top collaborators
No co-investigators on record.
Most similar at Progenics Pharmaceuticals, Inc.
Same institution · by research overlap
- Gerald P Donovan$9,061,908
- Glen Andrew Coburn$12,617,543
- Sofija Andjelic$844,694
- William C Olson$17,385,230
- Dangshe Ma$5,789,789
Others in their field
Top investigators on “Active Immunization”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$466,593,725
- Judith S. Currier · University Of California Los Angeles$322,872,111
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$256,197,143
- Daniel R Kuritzkes · Brigham And Women'S Hospital$217,875,923
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
Research focus
Active ImmunizationAntiviral AgentsBioassayBioreactorsCell LineCell Mediated Lymphocytolysis TestCellular ImmunityClinical ResearchDrug Screening /EvaluationEnzyme Linked Immunosorbent AssayGenetically Modified AnimalsGlycoproteinsHepatitis CHepatitis C VirusHigh Throughput TechnologyHuman TissueHumoral ImmunityLaboratory MouseLiver CellsMaleMethod DevelopmentMonoclonal AntibodyNeoplasm /Cancer VaccineProstate Neoplasms
Grant awards (4)
Development of Hepatitis C Virus entry inhibitors$294,489
R43 · FY2003 · AI
Alphavirus prime-boost vaccines for prostate cancer$181,329
R43 · FY2003 · CA
Development of Hepatitis C Virus entry inhibitors$300,000
R43 · FY2002 · AI
Alphavirus prime-boost vaccines for prostate cancer$185,206
R43 · FY2002 · CA